Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study

Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study

BackgroundLow-density lipoprotein cholesterol (LDL-C) is the primary target of lipid-lowering therapy on the management of hypercholesterolemia in the United States and European guidelines, while apolipoprotein B (apoB) is the secondary target. The objective was to determine if elevated levels of ap...

Full description

Bibliographic Details
Main Authors: Tianci Yao, Weilin Lu, Jinshan Ke, Hao Zhang, Xiaofang Zhao, Bei Song, Ting Liu, Qinmei Ke, Chengyun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Endocrinology
Subjects:
statin
ApoB
LDL-C
coronary atherosclerotic heart disease
residual risk
coronary atherosclerosis
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.865863/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.865863/full

Similar Items